Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

Emily Kozera, Akshay Flora, John W. Frew

2022Journal of the American Academy of Dermatology56 citationsDOI

Topics & Concepts

Hidradenitis suppurativaMedicineScopusDermatologyClinical trialJanus kinasePsoriasisMEDLINEOncologyInternal medicineDiseaseCytokinePolitical scienceLawHidradenitis Suppurativa and Treatments